Rhumbline Advisers Purchases 14,647 Shares of The Clorox Company (NYSE:CLX)

Rhumbline Advisers lifted its holdings in The Clorox Company (NYSE:CLX - Free Report) by 5.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 273,462 shares of the company's stock after buying an additional 14,647 shares during the period. Rhumbline Advisers owned about 0.22% of Clorox worth $40,267,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CLX. Redwood Park Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter worth $26,000. Millstone Evans Group LLC acquired a new stake in shares of Clorox in the fourth quarter worth $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the fourth quarter valued at $31,000. Asset Planning Inc acquired a new stake in Clorox during the fourth quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Clorox during the fourth quarter valued at $32,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The stock was bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director now directly owns 4,000 shares in the company, valued at $546,280. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.57% of the company's stock.

Clorox Stock Performance

Shares of NYSE:CLX traded down $2.41 during midday trading on Thursday, hitting $127.24. The company's stock had a trading volume of 1,889,670 shares, compared to its average volume of 1,346,224. The Clorox Company has a fifty-two week low of $127.01 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market capitalization of $15.68 billion, a price-to-earnings ratio of 34.77, a PEG ratio of 2.62 and a beta of 0.60. The stock's 50 day simple moving average is $137.40 and its 200 day simple moving average is $150.49.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm earned $1.71 earnings per share. The business's quarterly revenue was down 8.0% on a year-over-year basis. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CLX. JPMorgan Chase & Co. reduced their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a report on Tuesday, May 6th. UBS Group reduced their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Barclays decreased their target price on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. Wells Fargo & Company cut their price target on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, Evercore ISI set a $140.00 price objective on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.